| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |